Ditchcarbon
  • Customers
  1. Organizations
  2. Vectura
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 9 days ago

Vectura

Company website

Vectura Group plc, headquartered in Great Britain, is a leading player in the pharmaceutical industry, specialising in the development of inhalation products and drug delivery solutions. Founded in 1997, Vectura has achieved significant milestones, including partnerships with major pharmaceutical companies to enhance respiratory therapies. The company focuses on innovative formulations and device technologies, particularly for asthma and chronic obstructive pulmonary disease (COPD). Vectura's unique approach combines expertise in inhalation science with advanced manufacturing capabilities, positioning it as a trusted partner in the respiratory market. With a strong presence in Europe and North America, Vectura has established itself as a key contributor to improving patient outcomes through its core products and services. Its commitment to research and development continues to drive its success and market leadership in the inhalation therapeutics sector.

DitchCarbon Score

How does Vectura's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Vectura's score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Vectura's reported carbon emissions

In 2018, Vectura Group plc reported total carbon emissions of approximately 3,792,000 kg CO2e, comprising 2,543,000 kg CO2e from Scope 1 and 1,249,000 kg CO2e from Scope 2 emissions. This data reflects a slight increase from 2017, when total emissions were about 3,834,000 kg CO2e, with Scope 1 emissions at 2,312,000 kg CO2e and Scope 2 emissions at 1,522,000 kg CO2e. In contrast, emissions in 2014 were significantly lower, at around 1,414,000 kg CO2e, with Scope 1 emissions of 142,000 kg CO2e and Scope 2 emissions of 1,272,000 kg CO2e. Vectura has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The company is a current subsidiary of Vectura Group plc, and all emissions data is cascaded from this parent organization. The absence of Scope 3 emissions data indicates a potential area for future reporting and improvement. Overall, Vectura's emissions profile highlights the need for enhanced climate strategies and commitments to reduce its carbon footprint in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201420172018
Scope 1
142,000
0,000,000
0,000,000
Scope 2
1,272,000
0,000,000
0,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vectura's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vectura is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vectura is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Basilea Pharmaceutica

CH
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

MorphoSys

DE
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Ablynx NV

BE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Almirall

ES
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Orion

FI
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Pharma Mar

ES
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy